{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:07Z","timestamp":1792788307230,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81870622"],"award-info":[{"award-number":["81870622"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2022JJ30828 and 2023JJ30747"],"award-info":[{"award-number":["2022JJ30828 and 2023JJ30747"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for the Central Universities of Central South University","doi-asserted-by":"crossref","award":["2022ZZTS0947 and 2023ZZTS0585"],"award-info":[{"award-number":["2022ZZTS0947 and 2023ZZTS0585"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Degree& Postgraduate Education Reform Project of Central South University","award":["512190112"],"award-info":[{"award-number":["512190112"]}]},{"name":"Scientific Research Project of Hunan Provincial Health Commission","award":["C202303067096 and 202112070631"],"award-info":[{"award-number":["C202303067096 and 202112070631"]}]},{"name":"Bethune Charitable Foundation, BCF","award":["GX2021B04"],"award-info":[{"award-number":["GX2021B04"]}]},{"name":"Central Subsidy for Prevention and Control of Major Infectious Diseases and HANS CARING Inc"},{"name":"Hunan Province Smart Chronic Disease Management Clinical Medical Research Center","award":["2023SK4042"],"award-info":[{"award-number":["2023SK4042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"DOI":"10.1186\/s12891-025-08571-6","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T05:07:55Z","timestamp":1747112875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between bone turnover markers and FRAX predicted fracture risk in Chinese adults: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaoli","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuo","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"8571_CR1","doi-asserted-by":"crossref","unstructured":"Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94(6):646\u201350.","DOI":"10.1016\/0002-9343(93)90218-E"},{"issue":"3","key":"8571_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMcp1513724","volume":"374","author":"DM Black","year":"2016","unstructured":"Black DM, Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med. 2016;374(3):254\u201362.","journal-title":"N Engl J Med"},{"issue":"22","key":"8571_CR3","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMcp070341","volume":"356","author":"S Khosla","year":"2007","unstructured":"Khosla S, Melton LJ. 3rd. Clinical practice. Osteopenia. N Engl J Med. 2007;356(22):2293\u2013300.","journal-title":"N Engl J Med"},{"issue":"7","key":"8571_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00198-015-3093-2","volume":"26","author":"L Si","year":"2015","unstructured":"Si L, Winzenberg TM, Jiang Q, Chen M, Palmer AJ. Projection of osteoporosis-related fractures and costs in China: 2010\u20132050. Osteoporos Int. 2015;26(7):1929\u201337.","journal-title":"Osteoporos Int"},{"issue":"5","key":"8571_CR5","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00198-014-2655-z","volume":"25","author":"ES Siris","year":"2014","unstructured":"Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus MJ, et al. The clinical diagnosis of osteoporosis: a position statement from the National bone health alliance working group. Osteoporos Int. 2014;25(5):1439\u201343.","journal-title":"Osteoporos Int"},{"issue":"5","key":"8571_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00223-002-2104-4","volume":"73","author":"TE Dufresne","year":"2003","unstructured":"Dufresne TE, Chmielewski PA, Manhart MD, Johnson TD, Borah B. Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography. Calcif Tissue Int. 2003;73(5):423\u201332.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"8571_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","volume":"112","author":"SR Cummings","year":"2002","unstructured":"Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, et al. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med. 2002;112(4):281\u20139.","journal-title":"Am J Med"},{"issue":"6","key":"8571_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s001980050104","volume":"8","author":"EM Lochm\u00fcller","year":"1998","unstructured":"Lochm\u00fcller EM, Zeller JB, Kaiser D, Eckstein F, Landgraf J, Putz R, et al. Correlation of femoral and lumbar DXA and calcaneal ultrasound, measured in situ with intact soft tissues, with the in vitro failure loads of the proximal femur. Osteoporos Int. 1998;8(6):591\u20138.","journal-title":"Osteoporos Int"},{"issue":"2","key":"8571_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.11005\/jbm.2018.25.2.73","volume":"25","author":"BH Yoon","year":"2018","unstructured":"Yoon BH, Yu W. Clinical utility of biochemical marker of bone turnover: fracture risk prediction and bone healing. J Bone Metab. 2018;25(2):73\u20138.","journal-title":"J Bone Metab"},{"issue":"2","key":"8571_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruy\u00e8re O, Foldes AJ, Garnero P, Griesmacher A, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22(2):391\u2013420.","journal-title":"Osteoporos Int"},{"issue":"2","key":"8571_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1373\/clinchem.2016.259085","volume":"63","author":"MB Greenblatt","year":"2017","unstructured":"Greenblatt MB, Tsai JN, Wein MN. Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clin Chem. 2017;63(2):464\u201374.","journal-title":"Clin Chem"},{"issue":"3","key":"8571_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jbmr.5650110307","volume":"11","author":"P Garnero","year":"1996","unstructured":"Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Min Res. 1996;11(3):337\u201349.","journal-title":"J Bone Min Res"},{"issue":"5","key":"8571_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00774-006-0703-2","volume":"24","author":"YZ Pi","year":"2006","unstructured":"Pi YZ, Wu XP, Liu SP, Luo XH, Cao XZ, Xie H, et al. Age-related changes in bone biochemical markers and their relationship with bone mineral density in normal Chinese women. J Bone Min Metab. 2006;24(5):380\u20135.","journal-title":"J Bone Min Metab"},{"issue":"10","key":"8571_CR14","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","volume":"11","author":"P Garnero","year":"1996","unstructured":"Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Min Res. 1996;11(10):1531\u20138.","journal-title":"J Bone Min Res"},{"issue":"5","key":"8571_CR15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1359\/jbmr.2002.17.5.826","volume":"17","author":"P Garnero","year":"2002","unstructured":"Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study. J Bone Min Res. 2002;17(5):826\u201333.","journal-title":"J Bone Min Res"},{"issue":"7","key":"8571_CR16","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/jbmr.3471","volume":"33","author":"CJ Crandall","year":"2018","unstructured":"Crandall CJ, Vasan S, LaCroix A, LeBoff MS, Cauley JA, Robbins JA, et al. Bone turnover markers are not associated with hip fracture risk: A Case-Control study in the women\u2019s health initiative. J Bone Min Res. 2018;33(7):1199\u2013208.","journal-title":"J Bone Min Res"},{"key":"8571_CR17","doi-asserted-by":"publisher","first-page":"1013483","DOI":"10.3389\/fphar.2022.1013483","volume":"13","author":"Z Yang","year":"2022","unstructured":"Yang Z, Xuan S, Li W, Hu W, Tu P, Duan P. Clinical application of the fracture risk assessment tool in the general population and its correlation with bone turnover markers. Front Pharmacol. 2022;13:1013483.","journal-title":"Front Pharmacol"},{"key":"8571_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2014.03.010","volume":"64","author":"TE Finnes","year":"2014","unstructured":"Finnes TE, Lofthus CM, Meyer HE, Eriksen EF, Apalset EM, Tell GS, et al. Procollagen type 1 amino-terminal propeptide (P1NP) and risk of hip fractures in elderly Norwegian men and women. A NOREPOS study. Bone. 2014;64:1\u20137.","journal-title":"Bone"},{"issue":"2","key":"8571_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S8756-3282(00)00325-2","volume":"27","author":"RD Chapurlat","year":"2000","unstructured":"Chapurlat RD, Garnero P, Br\u00e9art G, Meunier PJ, Delmas PD. Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. Bone. 2000;27(2):283\u20136.","journal-title":"Bone"},{"key":"8571_CR20","doi-asserted-by":"crossref","unstructured":"Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Min Res. 1994;9(8):1137\u201341.","DOI":"10.1002\/jbmr.5650090802"},{"issue":"1","key":"8571_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00198-003-1517-x","volume":"15","author":"XP Wu","year":"2004","unstructured":"Wu XP, Liao EY, Zhang H, Shan PF, Cao XZ, Liu SP. Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in Mainland Chinese women and the diagnosis of osteoporosis. Osteoporos Int. 2004;15(1):71\u20139.","journal-title":"Osteoporos Int"},{"key":"8571_CR22","doi-asserted-by":"crossref","unstructured":"Dawson-Hughes B, Tosteson AN, Melton LJ 3rd, Baim S, Favus MJ, Khosla S, et al. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int. 2008;19(4):449\u201358.","DOI":"10.1007\/s00198-008-0559-5"},{"issue":"1","key":"8571_CR23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s12020-019-01951-8","volume":"65","author":"SY Liu","year":"2019","unstructured":"Liu SY, Huang M, Chen R, Ding N, Liu H, Xie ZJ, et al. Comparison of strategies for setting intervention thresholds for Chinese postmenopausal women using the FRAX model. Endocrine. 2019;65(1):200\u20136.","journal-title":"Endocrine"},{"key":"8571_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jcm11195694","volume":"11","author":"Z Wen","year":"2022","unstructured":"Wen Z, Li Y, Xu L, Yue C, Wang Q, Chen R, et al. Triglyceride Glucose-Body mass index is a reliable indicator of bone mineral density and risk of osteoporotic fracture in Middle-Aged and elderly nondiabetic Chinese individuals. J Clin Med. 2022;11:19.","journal-title":"J Clin Med"},{"issue":"1","key":"8571_CR25","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12891-022-05427-1","volume":"23","author":"N Xia","year":"2022","unstructured":"Xia N, Cai Y, Wang W, Bao C, Li Y, Xie Q, et al. Association of bone-related biomarkers with femoral neck bone strength. BMC Musculoskelet Disord. 2022;23(1):482.","journal-title":"BMC Musculoskelet Disord"},{"issue":"5","key":"8571_CR26","first-page":"304","volume":"92","author":"Y Mohamed","year":"2014","unstructured":"Mohamed Y, Haifa H, Datel O, Fadoua HN, Smeh BH, Mahbouba J, et al. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk]. Tunis Med. 2014;92(5):304\u201310.","journal-title":"Tunis Med"},{"issue":"6","key":"8571_CR27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S8756-3282(01)00614-7","volume":"29","author":"TP van Staa","year":"2001","unstructured":"van Staa TP, Dennison EM, Leufkens HG, Cooper C. Epidemiology of fractures in England and Wales. Bone. 2001;29(6):517\u201322.","journal-title":"Bone"},{"issue":"2","key":"8571_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1302\/0301-620X.80B2.0800243","volume":"80","author":"BR Singer","year":"1998","unstructured":"Singer BR, McLauchlan GJ, Robinson CM, Christie J. Epidemiology of fractures in 15,000 adults: the influence of age and gender. J Bone Joint Surg Br. 1998;80(2):243\u20138.","journal-title":"J Bone Joint Surg Br"},{"issue":"Suppl 1","key":"8571_CR29","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/S8756-3282(09)80004-5","volume":"13","author":"JA Kanis","year":"1992","unstructured":"Kanis JA, Pitt FA. Epidemiology of osteoporosis. Bone. 1992;13(Suppl 1):S7\u201315.","journal-title":"Bone"},{"issue":"1","key":"8571_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","volume":"34","author":"SC Schuit","year":"2004","unstructured":"Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study. Bone. 2004;34(1):195\u2013202.","journal-title":"Bone"},{"issue":"8","key":"8571_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s001980070064","volume":"11","author":"JA Kanis","year":"2000","unstructured":"Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A, et al. Long-term risk of osteoporotic fracture in Malm\u00f6. Osteoporos Int. 2000;11(8):669\u201374.","journal-title":"Osteoporos Int"},{"issue":"4","key":"8571_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s007740170029","volume":"19","author":"O Y\u00fcksel","year":"2001","unstructured":"Y\u00fcksel O, D\u00f6kmeta\u015f HS, Topcu S, Erselcan T, Sencan M. Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome. J Bone Min Metab. 2001;19(4):257\u201362.","journal-title":"J Bone Min Metab"},{"issue":"2","key":"8571_CR33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0015-0282(16)54837-7","volume":"57","author":"C Di Carlo","year":"1992","unstructured":"Di Carlo C, Shoham Z, MacDougall J, Patel A, Hall ML, Jacobs HS. Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea. Fertil Steril. 1992;57(2):314\u20139.","journal-title":"Fertil Steril"},{"issue":"12","key":"8571_CR34","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2337\/diacare.19.12.1388","volume":"19","author":"E Barrett-Connor","year":"1996","unstructured":"Barrett-Connor E, Kritz-Silverstein D. Does hyperinsulinemia preserve bone? Diabetes Care. 1996;19(12):1388\u201392.","journal-title":"Diabetes Care"},{"key":"8571_CR35","doi-asserted-by":"crossref","unstructured":"Zborowski JV, Cauley JA, Talbott EO, Guzick DS, Winters SJ. Clinical review 116: bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone. J Clin Endocrinol Metab. 2000;85(10):3496\u2013506.","DOI":"10.1210\/jcem.85.10.6902"},{"issue":"5","key":"8571_CR36","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1210\/jcem-61-5-905","volume":"61","author":"CC Johnston Jr","year":"1985","unstructured":"Johnston CC Jr., Hui SL, Witt RM, Appledorn R, Baker RS, Longcope C. Early menopausal changes in bone mass and sex steroids. J Clin Endocrinol Metab. 1985;61(5):905\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"8571_CR37","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/oxfordjournals.aje.a116943","volume":"139","author":"JA Cauley","year":"1994","unstructured":"Cauley JA, Gutai JP, Kuller LH, Scott J, Nevitt MC. Black-white differences in serum sex hormones and bone mineral density. Am J Epidemiol. 1994;139(10):1035\u201346.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"8571_CR38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1210\/jcem-69-3-533","volume":"69","author":"KK Steinberg","year":"1989","unstructured":"Steinberg KK, Freni-Titulaer LW, DePuey EG, Miller DT, Sgoutas DS, Coralli CH, et al. Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab. 1989;69(3):533\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"8571_CR39","doi-asserted-by":"crossref","unstructured":"Khosla S, Melton LJ 3rd, Atkinson EJ, O\u2019Fallon WM, Klee GG, Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable Estrogen. J Clin Endocrinol Metab. 1998;83(7):2266\u201374.","DOI":"10.1210\/jc.83.7.2266"},{"issue":"6","key":"8571_CR40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1530\/EJE-11-0353","volume":"165","author":"S Boonen","year":"2011","unstructured":"Boonen S, Pye SR, O\u2019Neill TW, Szulc P, Gielen E, Borghs H, et al. Influence of bone remodelling rate on quantitative ultrasound parameters at the calcaneus and DXA BMDa of the hip and spine in middle-aged and elderly European men: the European male ageing study (EMAS). Eur J Endocrinol. 2011;165(6):977\u201386.","journal-title":"Eur J Endocrinol"},{"key":"8571_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/JIR.S203590","volume":"12","author":"FY Azizieh","year":"2019","unstructured":"Azizieh FY, Shehab D, Al Jarallah K, Mojiminiyi O, Gupta R, Raghupathy R. Circulatory pattern of cytokines, adipokines and bone markers in postmenopausal women with low BMD. J Inflamm Res. 2019;12:99\u2013108.","journal-title":"J Inflamm Res"},{"issue":"11","key":"8571_CR42","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1097\/gme.0b013e31821d7ff7","volume":"18","author":"J Zhao","year":"2011","unstructured":"Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, et al. The levels of bone turnover markers in Chinese postmenopausal women: Peking vertebral fracture study. Menopause. 2011;18(11):1237\u201343.","journal-title":"Menopause"},{"issue":"1","key":"8571_CR43","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/os.12596","volume":"12","author":"XL Qu","year":"2020","unstructured":"Qu XL, Zheng B, Chen TY, Cao ZR, Qu B, Jiang T. Bone turnover markers and bone mineral density to predict osteoporotic fractures in older women: A retrospective comparative study. Orthop Surg. 2020;12(1):116\u201323.","journal-title":"Orthop Surg"},{"issue":"2","key":"8571_CR44","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00223-021-00930-4","volume":"112","author":"SD Vasikaran","year":"2023","unstructured":"Vasikaran SD, Miura M, Pikner R, Bhattoa HP, Cavalier E. Practical considerations for the clinical application of bone turnover markers in osteoporosis. Calcif Tissue Int. 2023;112(2):148\u201357.","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"8571_CR45","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1359\/jbmr.090526","volume":"24","author":"DC Bauer","year":"2009","unstructured":"Bauer DC, Garnero P, Harrison SL, Cauley JA, Eastell R, Ensrud KE, et al. Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study. J Bone Min Res. 2009;24(12):2032\u20138.","journal-title":"J Bone Min Res"},{"issue":"5","key":"8571_CR46","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s00223-014-9842-y","volume":"94","author":"H Johansson","year":"2014","unstructured":"Johansson H, Od\u00e9n A, Kanis JA, McCloskey EV, Morris HA, Cooper C, et al. A meta-analysis of reference markers of bone turnover for prediction of fracture. Calcif Tissue Int. 2014;94(5):560\u20137.","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"8571_CR47","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1359\/JBMR.040512","volume":"19","author":"DC Bauer","year":"2004","unstructured":"Bauer DC, Black DM, Garnero P, Hochberg M, Ott S, Orloff J, et al. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J Bone Min Res. 2004;19(8):1250\u20138.","journal-title":"J Bone Min Res"},{"issue":"4","key":"8571_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1359\/JBMR.041207","volume":"20","author":"C Meier","year":"2005","unstructured":"Meier C, Nguyen TV, Center JR, Seibel MJ, Eisman JA. Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study. J Bone Min Res. 2005;20(4):579\u201387.","journal-title":"J Bone Min Res"},{"key":"8571_CR49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bone.2015.11.005","volume":"83","author":"Z Dai","year":"2016","unstructured":"Dai Z, Wang R, Ang LW, Yuan JM, Koh WP. Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population. Bone. 2016;83:171\u20137.","journal-title":"Bone"},{"issue":"3","key":"8571_CR50","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00198-005-2025-y","volume":"17","author":"SW Veitch","year":"2006","unstructured":"Veitch SW, Findlay SC, Hamer AJ, Blumsohn A, Eastell R, Ingle BM. Changes in bone mass and bone turnover following tibial shaft fracture. Osteoporos Int. 2006;17(3):364\u201372.","journal-title":"Osteoporos Int"},{"issue":"8","key":"8571_CR51","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1359\/jbmr.070505","volume":"22","author":"KK Ivaska","year":"2007","unstructured":"Ivaska KK, Gerdhem P, Akesson K, Garnero P, Obrant KJ. Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women. J Bone Min Res. 2007;22(8):1155\u201364.","journal-title":"J Bone Min Res"},{"issue":"4","key":"8571_CR52","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.afos.2019.12.002","volume":"5","author":"S Lekamwasam","year":"2019","unstructured":"Lekamwasam S. The diversity of fracture risk assessment tool (FRAX)-based intervention thresholds in Asia. Osteoporos Sarcopenia. 2019;5(4):104\u20138.","journal-title":"Osteoporos Sarcopenia"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-08571-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-025-08571-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-08571-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:04:54Z","timestamp":1747155894000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-025-08571-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8571"],"URL":"https:\/\/doi.org\/10.1186\/s12891-025-08571-6","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"11 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of The Second Xiangya Hospital at South China University, Changsha, China, approved this study (Approval Number: LYF20210015). We conducted all methods in compliance with pertinent guidelines and regulations, adhering to the principles of the Declaration of Helsinki. Participants were informed about the study\u2019s objectives, the significance of their involvement, and the assessment procedures. Upon agreement, each participant provided their signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"467"}}